US2007298473A1PendingUtilityA1
Pet family of efflux proteins
Individually held — no corporate assignee on recordPriority: Jan 17, 2003Filed: Aug 6, 2007Published: Dec 27, 2007
Est. expiryJan 17, 2023(expired)· nominal 20-yr term from priority
C07K 14/245C12P 7/40
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods of increasing the production of aromatic carboxylic acids from a host cell via manipulation of the yhcRQP operon encoding a family of efflux proteins. Up-regulation of all or a sub-set of the genes in the yhcRQP were additionally found to enhance tolerance to aromatic carboxylic acids toxicity.
Claims
exact text as granted — not AI-modified1 . A method of increasing the yield of an aromatic carboxylic acid from a host cell producing said aromatic carboxylic acid comprising:
a) providing a host cell which:
i) produces an aromatic carboxylic acid; and
ii) comprises at least one yhcQ gene and at least one yhcP gene; and
b) up-regulating the expression of the at least one yhcQ gene and the at least one yhcP gene whereby the yield of aromatic carboxylic acid is increased.
2 . (canceled)
3 . A method according to claim 1 wherein the at least one yhcQ gene and the at least one yhcP gene are endogenous to said host cell.
4 . A method according to claim 1 wherein the at least one yhcQ gene and the at least one yhcP gene are heterologous to said host cell.
5 . A method according to claim 1 wherein the host cell is selected from the group consisting of bacteria, yeast, fungi and plants.
6 . A method according to claim 5 wherein the host cell is an enteric bacteria.
7 . A method according to claim 5 wherein the host cell is selected from the group of genera consisting of Escherichia, Salmonella, Bacillus, Acinetobacter, Streptomyces, Methylobacter, Rhodococcus, Corynebacterium, Pseudomonas, Rhodobacter , and Synechocystis.
8 . A method according to claim 1 wherein the aromatic carboxylic acid is selected from the group consisting of para-hydroxybenzoic acid, para-hydroxycinnamic acid, cinnamic acid, salicylic acid, benzoic acid, and 1-napthoic acid.
9 . A method according to claim 1 wherein the at least one yhcQ gene and the at least one yhcP gene comprise at least one suitable promoter operably linked to at least one isolated nucleic acid molecule selected from the group consisting of SEQ ID NO:1-4.
10 . A method according to claim 1 wherein the at least one yhcP gene comprises a suitable promoter operably linked to an isolated nucleic acid molecule encoding the amino acid sequence as set forth in SEQ ID NO:5.
11 . A method according to claim 1 wherein the at least one yhcQ gene and the at least one yhcP gene are expressed on a multicopy plasmid.
12 . A method according to claim 1 wherein the at least one yhcQ gene and the at least one yhcP gene are under the control of a strong promoter.
13 . A method according to claim 12 wherein the strong promoter is selected from the group consisting of lac, trp, IP L , IP R , T7, tac, and trc.
14 . A chimeric gene encoding an efflux protein comprising:
a) an isolated nucleic acid molecule having a nucleic acid sequence selected from the group consisting of:
i) an isolated nucleic acid molecule selected from the group consisting of SEQ ID NO:1-4; and
ii) an isolated nucleic acid molecule, wherein said isolated nucleic acid molecule hybridizes with (i) under the following conditions: 0.1×SSC, 0.1% SDS at 65° C. and washed with 2×SSC, 0.1% SDS followed by a second wash in 0.2×SSC, 0.1% SDS; and
b) a promoter; wherein the promoter is heterologous to the isolated nucleic acid molecule.Join the waitlist — get patent alerts
Track US2007298473A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.